{"organizations": [], "uuid": "da0ccc043c3d68dc81812facde13a2acc29ea285", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-minerva-neurosciences-reports-fisc/brief-minerva-neurosciences-reports-fiscal-2017-fourth-quarter-and-year-end-financial-results-idUSASC09RQX", "country": "US", "domain_rank": 408, "title": "BRIEF-Minerva Neurosciences Reports Fiscal 2017 Fourth Quarter And Year End Financial Results", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-12T13:46:00.000+02:00", "replies_count": 0, "uuid": "da0ccc043c3d68dc81812facde13a2acc29ea285"}, "author": "", "url": "https://www.reuters.com/article/brief-minerva-neurosciences-reports-fisc/brief-minerva-neurosciences-reports-fiscal-2017-fourth-quarter-and-year-end-financial-results-idUSASC09RQX", "ord_in_thread": 0, "title": "BRIEF-Minerva Neurosciences Reports Fiscal 2017 Fourth Quarter And Year End Financial Results", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "minerva neurosciences", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "thomson reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "minerva neurosciences inc", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 12, 2018 / 11:46 AM / Updated 11 minutes ago BRIEF-Minerva Neurosciences Reports Fiscal 2017 Fourth Quarter And Year End Financial Results Reuters Staff March 12 (Reuters) - Minerva Neurosciences Inc: * MINERVA NEUROSCIENCES REPORTS FISCAL 2017 FOURTH QUARTER AND YEAR END FINANCIAL RESULTS AND BUSINESS UPDATES * Q4 EARNINGS PER SHARE $0.00 * Q4 EARNINGS PER SHARE VIEW $-0.38 â€” THOMSON REUTERS I/B/E/S * MINERVA NEUROSCIENCES - SEES EXISTING CASH & CASH EQUIVALENTS WILL BE SUFFICIENT TO MEET ANTICIPATED CAPITAL REQUIREMENTS FOR AT LEAST NEXT 12 MONTHS * MINERVA NEUROSCIENCES - CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF DECEMBER 31, 2017 WERE ABOUT $133.2 MILLION Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-12T13:46:00.000+02:00", "crawled": "2018-03-12T14:04:45.018+02:00", "highlightTitle": ""}